Stocks making the biggest moves premarket: Amazon, Snap, Ford and more

cnbc.com:

In this article

Check out the companies making headlines before the bell:

Regeneron Pharmaceuticals (REGN) – The drugmaker reported adjusted quarterly earnings of $23.72 per share, beating the $18.35 consensus estimate. Revenue also topped the forecast on strong sales of the company's Covid-19 antibody therapy as well as its eye drug Eylea. Regeneron said it is «working hard» to develop an updated therapy that will be effective against Omicron and other Covid-19 variants.

Bristol-Myers (BMY) – Bristol-Myers rose 1% in premarket trading after the drugmaker reported better than expected quarterly profit and revenue that was just slightly below estimates. The company also reaffirmed its long-term forecasts and announced a $15 billion share-repurchase authorization.

BJ's Wholesale (BJ) – The warehouse retailer's stock rose 2% in the premarket after Deutsche Bank upgraded it to «buy» from «hold.» Deutsche Bank points to the stock's 10% pullback so far this year as well as a shift in consumer buying habits to more value-oriented retailers.

Amazon.com (AMZN) – Amazon reported adjusted quarterly earnings of $5.80 per share, well above the $3.57 consensus estimate. Revenue was slightly below forecasts, but Amazon was helped by cost controls and strong performances in its cloud computing and ad businesses. Amazon also announced a $20 per year increase in membership fees for its Prime program to $139 per year, and the shares surged 11.8% in premarket trading.

Clorox (CLX) – Clorox tumbled 12.9% in premarket action after it fell 18 cents short of forecasts with adjusted quarterly profit of 66 cents per share. The maker of household products saw revenue come in slightly above estimates, but it was hit by considerably lower profit